{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T15:39:17Z","timestamp":1775576357729,"version":"3.50.1"},"reference-count":27,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,6,24]],"date-time":"2018-06-24T00:00:00Z","timestamp":1529798400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista de Gastroenterolog\u00eda de M\u00e9xico"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.rgmx.2018.04.005","type":"journal-article","created":{"date-parts":[[2018,7,27]],"date-time":"2018-07-27T20:19:00Z","timestamp":1532722740000},"page":"274-283","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Erradicaci\u00f3n de Helicobacter pylori en M\u00e9xico con un esquema basado en levofloxacina versus la triple terapia est\u00e1ndar: resultados de un estudio cl\u00ednico de fase iiib, abierto, aleatorizado, de no inferioridad"],"prefix":"10.1016","volume":"84","author":[{"given":"L.","family":"Ladr\u00f3n-de-Guevara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Bornstein-Quevedo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Gonz\u00e1lez-Huezo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Casta\u00f1eda-Romero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.G.","family":"Costa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"di Silvio-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rgmx.2018.04.005_bib0140","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1158\/1055-9965.EPI-05-0113","article-title":"Trends in Helicobacter pylori infection and gastric cancer in Mexico","volume":"14","author":"Torres","year":"2005","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.rgmx.2018.04.005_bib0145","doi-asserted-by":"crossref","first-page":"224","DOI":"10.59566\/IJBS.2013.9224","article-title":"Seroepidemiology of Helicobacter pylori infection in pregnant women in rural Durango, Mexico","volume":"9","author":"Alvarado Esquivel","year":"2013","journal-title":"Int J Biomed Sci"},{"key":"10.1016\/j.rgmx.2018.04.005_bib0150","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1136\/gutjnl-2012-302084","article-title":"Management of Helicobacter pylori infection \u2014the Maastricht IV\/Florence consensus report","volume":"61","author":"Malfertheiner","year":"2012","journal-title":"Gut"},{"key":"10.1016\/j.rgmx.2018.04.005_bib0155","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1128\/JCM.39.7.2677-2680.2001","article-title":"Increasing multidrug resistance in Helicobacter pylori strains isolated from children and adults in Mexico","volume":"39","author":"Torres","year":"2001","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.rgmx.2018.04.005_bib0160","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0140-6736(11)60825-8","article-title":"14-day triple, 5-day concomitant, and 10-day sequential therapies for Helicobacter pylori infection in 7Latin American sites: A randomised trial","volume":"378","author":"Greenberg","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.rgmx.2018.04.005_bib0165","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1089\/mdr.2010.0154","article-title":"Resistance to antibiotics and characterization of Helicobacter pylori strains isolated from antrum and body from adults in Mexico","volume":"17","author":"Ayala","year":"2011","journal-title":"Microbial Drug Resistance"},{"key":"10.1016\/j.rgmx.2018.04.005_bib0170","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.meegid.2016.06.044","article-title":"Clarithromycin resistance and prevalence of Helicobacter pylori virulent genotypes in patients from Southern M\u00e9xico with chronic gastritis","volume":"44","author":"Alarc\u00f3n Mill\u00e1n","year":"2016","journal-title":"Infection, Genetics and Evolution"},{"key":"10.1016\/j.rgmx.2018.04.005_bib0175","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/j.1365-2036.2007.03384.x","article-title":"First-line triple therapy with levofloxacin for Helicobacter pylori eradication","volume":"26","author":"Gisbert","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.rgmx.2018.04.005_bib0180","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.dld.2009.05.013","article-title":"Efficacy of 4different moxifloxacin-based triple therapies for first-line H. pylori treatment","volume":"42","author":"Sacco","year":"2010","journal-title":"Dig Liver Dis."},{"key":"10.1016\/j.rgmx.2018.04.005_bib0185","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/ajg.2014.24","article-title":"The problem of Helicobacter pylori resistance to antibiotics: A systematic review in Latin America","volume":"109","author":"Camargo","year":"2014","journal-title":"Am J Gastroenterol."},{"key":"10.1016\/j.rgmx.2018.04.005_bib0190","doi-asserted-by":"crossref","first-page":"164","DOI":"10.5662\/wjm.v5.i3.164","article-title":"Prevalence of antibiotic resistance in Helicobacter pylori: A recent literature review","volume":"5","author":"Ghotaslou","year":"2015","journal-title":"World J Methodol"},{"key":"10.1016\/j.rgmx.2018.04.005_bib0195","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.rgmx.2013.03.003","article-title":"Tratamiento ideal del Helicobacter pylori: una revisi\u00f3n sistem\u00e1tica","volume":"79","author":"Sierra","year":"2014","journal-title":"Revista de Gastroenterolog\u00eda de M\u00e9xico."},{"key":"10.1016\/j.rgmx.2018.04.005_bib0200","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1097\/00000478-199610000-00001","article-title":"Classification and grading of gastritis: The updated Sydney system","volume":"20","author":"Dixon","year":"1996","journal-title":"Am J Surg Pathol."},{"key":"10.1016\/j.rgmx.2018.04.005_bib0205","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/j.1523-5378.2007.00483.x","article-title":"Detection of Helicobacter pylori and determination of clarithromycin susceptibility using formalin-fixed, paraffin-embedded gastric biopsy specimens by fluorescence in situ hybridization","volume":"12","author":"Yilmaz","year":"2007","journal-title":"Helicobacter"},{"key":"10.1016\/j.rgmx.2018.04.005_bib0210","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1001\/jama.295.10.1152","article-title":"Reporting of noninferiority and equivalence randomized trials, an extension of the CONSORT Statement","volume":"295","author":"Piaggio","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.rgmx.2018.04.005_bib0215","unstructured":"Guideline on the choice of the non-inferiority margin. EMEA 2005. Doc. Ref. EMEA\/CPMP\/EWP\/2158\/99."},{"key":"10.1016\/j.rgmx.2018.04.005_bib0220","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1111\/j.1523-5378.2003.00179.x","article-title":"Eradication of Helicobacter pylori by 7-day triple-therapy regimens combining pantoprazole with clarithromycin, metronidazole, or amoxicillin in patients with peptic ulcer disease: Results of two double-Blind, randomized studies","volume":"8","author":"Bochenek","year":"2003","journal-title":"Helicobacter"},{"key":"10.1016\/j.rgmx.2018.04.005_bib0225","doi-asserted-by":"crossref","first-page":"126","DOI":"10.3855\/jidc.427","article-title":"Antibiotic resistance in Mexico: A brief overview of the current status and its causes","volume":"4","author":"Am\u00e1bile Cuevas","year":"2010","journal-title":"J Infect Dev Ctries"},{"key":"10.1016\/j.rgmx.2018.04.005_bib0230","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.curtheres.2007.03.005","article-title":"Resistance of uropathogenic bacteria to first-line antibiotics in Mexico City: A multicenter susceptibility analysis","volume":"68","author":"Arredondo Garc\u00eda","year":"2007","journal-title":"Curr Ter Res"},{"key":"10.1016\/j.rgmx.2018.04.005_bib0235","doi-asserted-by":"crossref","first-page":"528","DOI":"10.3109\/00365521.2014.887765","article-title":"Is levofloxacin-based triple therapy an alternative for first-line eradication of Helicobacter pylori? A systematic review and meta-analysis","volume":"49","author":"Xiao","year":"2014","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.rgmx.2018.04.005_bib0240","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1056\/NEJMoa1003833","article-title":"Azithromycin and the risk of cardiovascular death","volume":"366","author":"Wayne","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rgmx.2018.04.005_bib0245","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1128\/CMR.00033-06","article-title":"Helicobacter detection and antimicrobial susceptibility testing","volume":"20","author":"Megraud","year":"2007","journal-title":"Clinical Microbiol Rev"},{"key":"10.1016\/j.rgmx.2018.04.005_bib0250","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1128\/AAC.01131-10","article-title":"Genotypic resistance in Helicobacter pylori strains correlates with susceptibility test and treatment outcomes after levofloxacin and clarithromycin-based therapies","volume":"55","author":"Liou","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.rgmx.2018.04.005_bib0255","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1111\/j.1365-2036.2004.02203.x","article-title":"13C-urea breath test in the diagnosis of Helicobacter pylori infection \u2014a critical review","volume":"20","author":"Gisbert","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.rgmx.2018.04.005_bib0260","first-page":"357","article-title":"First- and second-line Helicobacter pylori eradication with modified sequential therapy and modified levofloxacin-amoxicillin-based triple therapy","volume":"27","author":"Zullo","year":"2014","journal-title":"Ann Gastroenterol"},{"key":"10.1016\/j.rgmx.2018.04.005_bib0265","first-page":"254","article-title":"Replacement of clarithromycin with azithromycin in triple therapy regimens for the eradication of Helicobacter pylori: A randomized clinical trial","volume":"7","author":"Khoshnood","year":"2014","journal-title":"J Med Life"},{"key":"10.1016\/j.rgmx.2018.04.005_bib0270","first-page":"302","article-title":"Estadificaci\u00f3n de la gastritis con el sistema OLGA; prevalencia de estadios avanzados de atrofia g\u00e1strica en pacientes mexicanos","volume":"76","author":"Ram\u00edrez Mendoza","year":"2011","journal-title":"Rev Gastroenterol Mex"}],"container-title":["Revista de Gastroenterolog\u00eda de M\u00e9xico"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0375090618301320?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0375090618301320?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,8]],"date-time":"2024-07-08T18:53:34Z","timestamp":1720464814000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0375090618301320"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["S0375090618301320"],"URL":"https:\/\/doi.org\/10.1016\/j.rgmx.2018.04.005","relation":{},"ISSN":["0375-0906"],"issn-type":[{"value":"0375-0906","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Erradicaci\u00f3n de Helicobacter pylori en M\u00e9xico con un esquema basado en levofloxacina versus la triple terapia est\u00e1ndar: resultados de un estudio cl\u00ednico de fase iiib, abierto, aleatorizado, de no inferioridad","name":"articletitle","label":"Article Title"},{"value":"Revista de Gastroenterolog\u00eda de M\u00e9xico","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rgmx.2018.04.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Asociaci\u00f3n Mexicana de Gastroenterolog\u00eda. Published by Masson Doyma M\u00e9xico S.A.","name":"copyright","label":"Copyright"}]}}